178 related articles for article (PubMed ID: 23677699)
1. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation.
Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D
Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699
[TBL] [Abstract][Full Text] [Related]
2. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5'-hydantoins.
Bakalova A; Buyukliev R; Momekov G; Ivanov D; Todorov D; Konstantinov S; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):590-6. PubMed ID: 15922842
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity of platinum(II) complexes of 3-aminocyclopentanespiro-5-hydantoin and 3-aminocycloheptanespiro-5-hydantoin.
Kushev D; Naydenova E; Popova J; Maneva L; Grancharov K; Spassovska N
Z Naturforsch C J Biosci; 2003; 58(1-2):103-8. PubMed ID: 12622235
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides.
Zhao G; Lin H; Zhu S; Sun H; Chen Y
Anticancer Drug Des; 1998 Oct; 13(7):769-77. PubMed ID: 9807161
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands.
Bakalova A; Buyukliev R; Tcholakova I; Momekov G; Konstantinov S; Karaivanova M
Eur J Med Chem; 2003 Jun; 38(6):627-32. PubMed ID: 12832135
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and biological activity of Pt(II) and Pt(IV) complexes with 5-methyl-5(4-pyridyl)-2,4-imidazolidenedione.
Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ferdinandov D; Konstantinov S; Ivanov D
Eur J Med Chem; 2008 May; 43(5):958-65. PubMed ID: 17707952
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity, antibacterial and antitumor activity of platinum(II) complexes of 3-aminocyclohexanespiro-5-hydantoin.
Kushev D; Gorneva G; Enchev V; Naydenova E; Popova J; Taxirov S; Maneva L; Grancharov K; Spassovska N
J Inorg Biochem; 2002 Apr; 89(3-4):203-11. PubMed ID: 12062124
[TBL] [Abstract][Full Text] [Related]
10. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
11. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
12. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
Rakić GM; Grgurić-Šipka S; Kaluđerović GN; Bette M; Filipović L; Aranđelović S; Radulović S; Tešić ZLj
Eur J Med Chem; 2012 Sep; 55():214-9. PubMed ID: 22858225
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of new Pt(II) and Pd(II) complexes with 2-quinolinecarboxaldehyde selenosemicarbazone: cytotoxic activity evaluation of Cd(II), Zn(II), Ni(II), Pt(II) and Pd(II) complexes with heteroaromatic selenosemicarbazones.
Gligorijević N; Todorović T; Radulović S; Sladić D; Filipović N; Godevac D; Jeremić D; Andelković K
Eur J Med Chem; 2009 Apr; 44(4):1623-9. PubMed ID: 18789831
[TBL] [Abstract][Full Text] [Related]
14. Pd(II) and Pd(IV) complexes with 5-methyl-5-(4-pyridyl)hydantoin: synthesis, physicochemical, theoretical, and pharmacological investigation.
Sabounchei SJ; Shahriary P; Salehzadeh S; Gholiee Y; Nematollahi D; Chehregani A; Amani A; Afsartala Z
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():1019-31. PubMed ID: 25171052
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study.
Ananda Kumar CS; Kavitha CV; Vinaya K; Benaka Prasad SB; Thimmegowda NR; Chandrappa S; Raghavan SC; Rangappa KS
Invest New Drugs; 2009 Aug; 27(4):327-37. PubMed ID: 18839066
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and mutagenicity of new cis-[Pt(2-substituted-benzimidazole)2Cl2] complexes.
Gümüş F; Demirci AB; Ozden T; Eroğlu H; Diril N
Pharmazie; 2003 May; 58(5):303-7. PubMed ID: 12779045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
